By Counterforce Health Team in Turalio (pexidartinib) —

How to Get Turalio (Pexidartinib) Covered by Cigna in Florida: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Turalio Covered by Cigna in Florida

Cigna requires prior authorization for Turalio (pexidartinib) to treat symptomatic tenosynovial giant cell tumor (TGCT) not amenable to surgery. Your fastest path to approval: (1) Ensure both prescriber and patient complete REMS enrollment before submission, (2) Submit complete PA documentation including pathology report with ICD-10 code M12.2, surgical assessment, and baseline liver tests via Express Scripts portal, and (3) If denied, file internal appeal within 180 days using clinical evidence and policy language. Standard PA decisions take 3-14 days; appeals take 30 days with external review available through Florida Department of Financial Services.

Table of Contents

  1. Who Should Use This Guide
  2. Member & Plan Basics
  3. Clinical Criteria Requirements
  4. Coding & Documentation Requirements
  5. Step-by-Step: Fastest Path to Approval
  6. Common Denial Reasons & How to Fix Them
  7. Appeals Playbook for Florida
  8. Specialty Pharmacy Process
  9. Costs & Savings Options
  10. FAQ

Who Should Use This Guide

This guide is for Florida patients with tenosynovial giant cell tumor (TGCT) whose doctors have prescribed Turalio (pexidartinib), and their healthcare teams navigating Cigna's coverage requirements. You'll need this if:

  • Your doctor believes surgery isn't appropriate for your TGCT
  • You're experiencing severe symptoms or functional limitations
  • Cigna has denied initial coverage or you want to prevent denial
  • You need to understand the REMS program requirements

Expected outcome: Following this guide increases your chances of approval by ensuring complete documentation and proper REMS enrollment before submission.

Member & Plan Basics

Coverage Requirements

  • Active Cigna coverage with prescription benefits
  • Specialty drug coverage through Express Scripts/Accredo
  • Prior authorization required for all Turalio prescriptions
  • 12-month initial approval period with reauthorization required

Plan Verification Steps

  1. Log into myCigna portal to confirm active coverage
  2. Check if your plan includes Accredo specialty pharmacy benefits
  3. Verify your deductible status and specialty tier copays
  4. Call Cigna customer service at 800-882-4462 to confirm PA requirements

Clinical Criteria Requirements

Primary Indication

Cigna covers Turalio for adults with symptomatic TGCT (also called pigmented villonodular synovitis) that:

  • Causes severe morbidity or functional limitations
  • Is not amenable to improvement with surgery
  • Has been confirmed by pathology and imaging

Required Clinical Documentation

  • Confirmed TGCT diagnosis via pathology report
  • Imaging studies (MRI showing tumor extent and symptoms)
  • Surgical consultation documenting why surgery is not feasible or would worsen function
  • Baseline liver function tests (ALT, AST, total/direct bilirubin, ALP, GGT)
  • Documentation of symptoms and functional impact
Clinician Corner: Your medical necessity letter should address why surgery isn't appropriate—whether due to location, size, patient factors, or risk of functional impairment. Include specific functional assessments and how TGCT impacts daily activities.

Coding & Documentation Requirements

Essential Codes

  • ICD-10: M12.2 (Villonodular synovitis/pigmented villonodular synovitis)
  • NDC codes: Available for 125 mg and 200 mg capsules
  • No J-code: Turalio is oral, billed through pharmacy benefit

Documentation Packet Checklist

  • Pathology report with TGCT confirmation
  • MRI or other imaging showing tumor characteristics
  • Surgical consultation notes explaining non-surgical approach
  • Baseline liver function tests within 30 days
  • Provider attestation of REMS enrollment completion
  • Patient enrollment confirmation in TURALIO REMS program

Step-by-Step: Fastest Path to Approval

1. Complete REMS Enrollment (1-3 days)

Who: Prescriber and patient
Action: Both enroll at turaliorems.com
Timeline: 1-3 business days for certification
Critical: Must be completed before PA submission

2. Gather Required Documentation (2-5 days)

Who: Healthcare team
Action: Collect pathology, imaging, surgical consult, labs
Documents: See documentation checklist above
Tip: Request records early as labs must be recent

3. Submit Complete PA (Same day)

Who: Prescriber or staff
Action: Submit via Express Scripts portal or fax 1-888-327-9791
Include: All documentation plus REMS confirmation
Timeline: 3-14 days for standard review

4. Track Submission Status (Ongoing)

Who: Patient or clinic
Action: Check myCigna portal or call 800-835-3784
Record: Confirmation numbers and review timeline
Follow-up: Contact if no response in 14 days

5. Address Any Requests (24-48 hours)

Who: Healthcare team
Action: Respond quickly to requests for additional information
Common requests: Updated labs, clarification on surgical assessment
Timeline: Respond within 48 hours to avoid delays

Common Denial Reasons & How to Fix Them

Denial Reason How to Overturn Required Documents
Missing TGCT diagnosis Submit pathology report with ICD-10 M12.2 Pathology report with clear TGCT diagnosis
Surgery not addressed Provide surgical consultation documenting non-feasibility Orthopedic/surgical consult notes explaining risks/limitations
REMS enrollment gaps Confirm both prescriber and patient enrollment REMS certification screenshots or confirmation emails
Incomplete liver monitoring Submit recent comprehensive liver panel ALT, AST, total/direct bilirubin, ALP, GGT within 30 days
Quantity limits exceeded Justify dosing with FDA labeling FDA prescribing information showing 250mg BID standard dose

Appeals Playbook for Florida

Internal Appeal Process

  • Deadline: 180 days from denial notice
  • Timeline: 30 days for decision (72 hours if urgent)
  • Submission: Via myCigna portal or fax 855-840-1678
  • Required: Original denial letter, updated clinical evidence, policy language rebuttal

Level 2 Internal Appeal

  • Automatic eligibility after Level 1 denial
  • Same timeline: 30 days standard, 72 hours urgent
  • Different reviewers evaluate your case
  • Include: Any new clinical evidence or guideline updates

External Review (Florida)

  • When: After exhausting internal appeals
  • Timeline: 45 days for decision (72 hours if urgent)
  • Cost: Free to patients
  • Contact: Florida Department of Financial Services at 1-877-693-5236
  • Deadline: 4 months after final internal denial
Note: External review decisions are binding on Cigna and provide independent medical expert evaluation of your case.

Specialty Pharmacy Process

Accredo Dispensing

Cigna uses Accredo for Turalio dispensing in Florida:

  1. Prescription routing: Provider sends to Accredo (NCPDP 2623735)
  2. Verification: Specialty pharmacists review for REMS compliance
  3. Patient counseling: Nurses provide administration training and monitoring guidance
  4. Home delivery: Free shipping to Florida addresses with tracking
  5. Ongoing support: 24/7 pharmacist access and refill coordination

Contact Information

  • Orders/refills: 7am-10pm CT
  • Clinical support: 24/7 availability
  • Florida resources: Available at accredo.com/fl

Costs & Savings Options

Financial Assistance Programs

  • Manufacturer copay card: Up to $25,000 annually for eligible insured patients
  • Accredo financial counseling: Connected $2.3 billion in copay assistance in 2022
  • Patient assistance programs: Available through Daiichi Sankyo Access Central

Medicare Considerations

For Medicare Part D beneficiaries, the 2025 out-of-pocket cap is $2,000 with voluntary prescription payment plans available to spread costs monthly.

Frequently Asked Questions

How long does Cigna prior authorization take for Turalio in Florida?
Standard PA takes 3-14 days with complete documentation. Expedited review available within 24 hours for urgent cases.

What if Turalio is non-formulary on my Cigna plan?
Request formulary exception through Cigna's exception process with clinical justification for medical necessity.

Can I request expedited appeal if denied?
Yes, if you can document clinical urgency. Submit request via myCigna portal or call 800-882-4462 for 72-hour expedited review.

Does step therapy apply to Turalio?
Generally no, as Turalio is first-line therapy for inoperable TGCT. However, document any prior treatments attempted.

What liver monitoring is required during treatment?
Weekly liver tests for 8 weeks, then every 2 weeks for 4 weeks, then every 3 months. This is FDA-mandated through the REMS program.

How do I check my appeal status?
Log into myCigna portal, call customer service at 800-882-4462, or contact your specialty pharmacy coordinator.

From our advocates: We've seen the biggest approval successes when patients complete REMS enrollment before their doctor submits the PA. This single step prevents the most common delay we encounter. Having both the prescriber and patient already certified shows payers you're serious about following the safety protocols.

About Counterforce Health

Counterforce Health helps patients, clinicians, and specialty pharmacies get prescription drugs approved by turning insurance denials into targeted, evidence-backed appeals. Our platform analyzes denial letters, plan policies, and clinical notes to identify the denial basis and draft point-by-point rebuttals using the right medical evidence and payer-specific requirements.

When working with complex cases like Turalio approvals, Counterforce Health streamlines the process by ensuring all REMS requirements, clinical documentation, and appeal strategies align with Cigna's specific policies and Florida's regulatory environment.

Sources & Further Reading

Disclaimer: This information is for educational purposes only and does not constitute medical advice. Always consult with your healthcare provider about your specific medical condition and treatment options. Insurance coverage policies can change; verify current requirements with your plan. For assistance with insurance appeals in Florida, contact the Department of Financial Services at 1-877-693-5236.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.